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Summary
Diaphanous-related formins (DRFs) regulate the nu-
cleation and polymerization of unbranched actin fila-
ments. The activity of DRFs is inhibited by an intramo-
lecular interaction between their N-terminal regulatory
region and a conserved C-terminal segment termed
the Diaphanous autoinhibitory domain (DAD). Binding
of GTP bound Rho to the mDia1 N terminus releases
this autoinhibitory restraint. Here, we describe the
crystal structure of the DAD segment of mDia1 in com-
plex with the relevant N-terminal fragment, termed the
DID domain. The structure reveals that the DAD seg-
ment forms an amphipathic helix that binds a con-
served, concave surface on the DID domain. Compari-
son with the structure of the mDia1 N terminus bound
to RhoC suggests that release of the autoinhibitory
DAD interaction is accomplished largely by Rho-
induced restructuring of the adjacent GTPase binding
subdomain (GBD), but also by electrostatic repulsion
and a small, direct steric occlusion of the DAD binding
cleft by Rho itself.
Introduction
Formin proteins nucleate new, unbranched actin fila-
ments (Pruyne et al., 2002; Sagot et al., 2002) that are
critical for many cellular processes, including cytokine-
sis, cell migration, and the establishment and mainte-
nance of cell polarity (Evangelista et al., 2003; Higgs,
2005; Wallar and Alberts, 2003). Phylogenetic analysis
reveals 15 formin genes in mammalian cells, which fall
into 7 distinct groups (Higgs and Peterson, 2005). The
Diaphanous-related formins (DRFs) are a subfamily of
formin proteins that are effectors for Rho-family
GTPases (Evangelista et al., 1997; Watanabe et al.,
1997). Murine formin mDia1, a mammalian homolog of
Drosophila Diaphanous (Castrillon and Wasserman,
1994), is a protein of 1255 residues that is required for
cytokinesis (Watanabe et al., 1997), Rho-induced forma-
tion of actin stress fibers (Nakano et al., 1999), and for
microtubule stabilization (Ishizaki et al., 2001; Palazzo
et al., 2001).
The conserved domain structure of DRFs includes,
from the N terminus to the C terminus, the GTPase bind-
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3 These authors contributed equally to this work.ing domain (GBD), the Diaphanous inhibitory domain
(DID), the dimerization domain (DD), a coiled-coil seg-
ment, the FH1 region, the highly conserved FH2 domain,
and the carboxy-terminal Diaphanous autoregulatory
domain (DAD) (Figure 1A). The GBD, DID, and DD do-
mains comprise the N-terminal regulatory apparatus of
DRFs, while the more C-terminal FH2 domain is respon-
sible for nucleation of actin filaments. The actin assem-
bly activity of the FH2 domain is inhibited by intramolec-
ular binding of the C-terminal DAD segment to the DID
domain, which is located within the N-terminal regula-
tory region (Alberts, 2001; Li and Higgs, 2005). The
GBD and DID domains of mDia1 together bind Rho-
GTP to effect release of the DAD segment and activate
formin for actin assembly (Rose et al., 2005). In the ab-
sence of Rho, the GBD subdomain is unstructured
with respect to the adjacent DID domain ([Otomo
et al., 2005a] and our unpublished data). The proline-
rich FH1 region recruits the actin binding protein profilin
(Chang et al., 1997; Evangelista et al., 1997; Imamura
et al., 1997), thus providing a mechanism by which to de-
liver actin monomers to the growing barbed end of actin
filaments (Carlier et al., 1999; Wear et al., 2000).
Recent structural studies have revealed the con-
served architecture of the FH2 domain (Shimada et al.,
2004; Xu et al., 2004) and its mode of interaction with ac-
tin (Otomo et al., 2005b), as well as the structure of the
N-terminal region of mDia1 alone (Otomo et al., 2005a)
and in complex with RhoC (Rose et al., 2005). In order
to better understand formin regulation, we determined
the structure of the autoinhibitory complex between
the DID and DAD regions of mDia1. The structure reveals
conserved interactions that stabilize the autoinhibited
state, and by comparison with the previous Rho bound
structure, it explains the mechanism of Rho activation.
Rho binding and Rho-induced restructuring of the adja-
cent GBD domain sterically occludes the DAD binding
surface. Additionally, Rho may promote release of auto-
inhibition by electrostaic repulsion of the bound DAD
peptide.
Results and Discussion
Structure of the Autoinhibited mDia1
DID/DAD Complex
We cocrystallized the DID domain (residues 131–369 of
murine mDia1) with the DAD segment (residues 1175–
1200) and refined the structure at 2.1 A˚ resolution (see
Table 1). The DID domain is composed of five armadillo
repeats, a structural motif of three helices arrayed in
a superhelical coil (Otomo et al., 2005a; Rose et al.,
2005). The DAD polypeptide binds along the entire
length of the domain, roughly perpendicular to the B he-
lices, and establishes an extensive interface through nu-
merous mainly hydrophobic contacts (Figure 1B). The
core of the DAD segment is an amphipathic helix, with
Gly1180 at its N terminus and Gly1192 at its C terminus,
which binds to the concave surface formed by the cen-
tral B helices of the five armadillo repeats. This central
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and C termini.
The hydrophobic face of the DAD helix, defined by
Val1181, Met1182, Leu1185, and Leu1189, packs in
a shallow groove on the DID domain (Figure 1C). DAD
residue Met1182 makes particularly extensive contact;
it inserts into a pocket formed by a ring of hydrophobic
residues on the DID domain that include Met216, Ile222,
Leu253, and Ala256 (Figure 2). Each end of the DAD helix
is anchored by a helix-capping hydrogen bond contrib-
uted by the DID domain; the side chains of conserved
residues Asn217 and Gln352 form hydrogen bonds
with the main chain amide and carbonyl groups of
DAD residues Met1182 and Leu1189, respectively. Addi-
tionally, the main chain carbonyl of Asn217 forms a hy-
drogen bond with Gly1180 on the DAD peptide. Just
N-terminal to the helix, DAD residues 1177–1179 bind
in an extended conformation and make only modest
contact with the DID domain. Asp1177 packs against
Val168, while Thr1179 makes a hydrogen interaction
via a bridging water molecule (not illustrated). On the
C-terminal side of the helix, residues 1192–1196 form
Figure 1. Structure of the mDia1 Autoinhibitory Apparatus
(A) Domain organization of mDia1. The complex between the DID
and DAD domains is presented here.
(B) Ribbon diagram showing the overall structure of the DID/DAD
complex. The DID domain is shown in blue, and the DAD domain
is shown in yellow. The B helices of armadillo repeats 1–5 are labeled
from left to right, and the N and C termini of the DAD domain are in-
dicated.
(C) Detailed view of the core of the DID/DAD interaction. Note that
the central portion of the bound DAD peptide (yellow) forms an am-
phipathic helix that makes extensive hydrophobic contact with the
DID domain (blue). Side chains of selected residues are shown in
stick form.a helical turn that projects perpendicular to the core he-
lix. Residue Phe1195 in this turn inserts into a pocket
formed by Ile259, Asn310, Thr314, and Val355 on the
DID domain (Figure 1C).
The DAD binding surface on the DID domain is highly
conserved among most Diaphanous-related formins
(Figure 3A). Mapping of conserved residues on the sur-
face of the DID domain, based on aligned sequences
of 30 DRFs, demonstrates that each of the 5 most highly
conserved surface residues (Asn217, Asn218, Ala256,
Asn310, and Gln352) participates in DAD recognition
(Figure 3B). Additionally, previous structure-function
studies of mDia regulation agree well with the observed
structure. In mDia2, alanine substitutions in DAD resi-
dues corresponding to Ser1184, Glu1187, and Gln1190
in mDia1 have no effect on autoinhibition, while substitu-
tion in positions corresponding to Met1182, Leu1185,
and Leu1189 each abrogate autoinhibition (Alberts,
2001). As shown in Figures 1C and 3B, each of the latter
residues is part of the core DAD domain interaction.
Similarly, previous mapping of the DAD binding site on
the surface of the DID domain based on sequence con-
servation, site directed mutagenesis, and NMR cross-
saturation experiments corresponds closely to the
observed binding surface (Otomo et al., 2005a; Rose
et al., 2005). Point mutations of DID domain residues
Asn217, Ile222, Ala256, Ile259, and Leu260 all decrease
DAD binding, and all lie within the DAD binding site
(Otomo et al., 2005a; Rose et al., 2005) (Figure 1C).
Relevant segments of the sequences of several repre-
sentative DRFs are aligned in Figure 3C. The DID and
Table 1. Summary of Data Collection and Refinement Statistics
DID/DAD Complex
Data Collection
Space group C2
Cell dimensions
a, b, c (A˚) 102.16, 65.79, 46.86
a = g, b (º) 90.00, 104.08
Resolution (A˚) 10–2.1
Rmerge
a 4.7 (35.6)
I/s(I) 10.86 (2.07)
Completeness (%) 89.6 (91.4)
Redundancy 2.14
Unique reflections 17,397
Refinement
Resolution (A˚) 8–2.1
Number of reflections 15,971
Rwork/Rfree (%)
b 21/28
Number of atoms
Protein 1,963
Water 126
Mean B factors (A˚2) 36.3
Rms deviations
Bond lengths (A˚) 0.006
Bond angles (º) 1.549
Ramachandran analysis (%)
Favored 93.2
Allowed 100
The highest-resolution shell is shown in parentheses.
a Rmerge =
P
hkljIhkl 2 <Ihkl>j/
P
hkl Ihkl, where Ihkl is the measured in-
tensity of the reflections with indices hkl.
b Rwork =
PkFoj2 jFck/
PjFoj; Rfree is the R for a subset of reflections
(5%) excluded from the refinement.
Structure of the Formin Autoinhibitory Mechanism
259Figure 2. The 2jFoj 2 jFcj Composite-Omit Map Contoured at 1.0s
The DID/DAD interface and, in particular, the positioning of Met1182 into a hydrophobic pocket on the DID domain (blue) is highlighted. The DAD
peptide is shown in yellow.DAD residues in the binding interface are conserved (or
conservatively substituted) among most DRFs, includ-
ing the mammalian formins mDia, Daam1 (Dishevelled-
associated activator of morphogenesis-1), and Fmnl1
(formin-like 1) and the yeast formin Bnr1p. Based upon
this sequence conservation and structural consider-
ations, we expect that the particular autoinhibitory bind-
ing mode we observe here will be general among these
DRFs. Interestingly, the binding interface is not suffi-
ciently conserved in the mammalian FHOD1 or in the
yeast Bni1p to allow us to confidently predict a closely
similar autoinhibitory interaction in these proteins, de-
spite the fact that both contain recognizable DID and
DAD domains. Thus, it is possible that some Diapha-
nous-related formins have evolved alternative autoinhi-
bitory mechanisms.
Calorimetric Analysis
of the Autoinhibitory Interaction
It is important to ask to what extent the isolated DID and
DAD segments studied here recapitulate the autoinhibi-
tory interaction in the intact protein. A dimeric mDia1
N-terminal fragment (residues 1–548) has been shown
to inhibit the actin assembly activity of an FH2+DAD
C-terminal construct with an IC50 of 2 nM, and to inhibit
an FH2-only fragment with an IC50 of 40 mM (Li and
Higgs, 2005). This DAD-independent inhibition, albeit
20,000-fold less potent, suggests the possibility of a sec-
ond site of interaction on the FH2 domain proper. To fur-
ther address these issues, we studied the binding of the
isolated DID and DAD domains and of longer N- and
C-terminal constructs by using isothermal titration calo-
rimetry (ITC, Figure 4). To avoid the confounding effect
of bivalent binding interactions, we used monomeric
N-terminal fragments containing either the DID or
GBD+DID regions. We measured binding of these con-
structs to a GST-DAD fusion protein and to an FH2+DAD
construct. The DID domain binds with a Kd of 240 nM to
the GST-DAD fusion, and with a modestly lower Kd of
102 nM to the FH2+DAD protein. The GBD region does
not appear to participate significantly, as the GBD+DIDconstruct binds the GST-DAD with a Kd of 97 nM and
to the FH2+DAD with a Kd of 57 nM. Each of these inter-
actions is endothermic and entropically driven. The en-
tropic nature of the binding is consistent with the hydro-
phobic binding interface between DID and DAD. GST
alone does not interact with either DID or GBD+DID
proteins (data not shown). Our measurements reveal
w7-fold tighter binding to the isolated DAD domain
than that reported by Rose et al. (2005), who measured
binding to a longer 40 residue DAD peptide and also
noted the entropically driven nature of the binding inter-
action. Our measurements agree well, however, with
those reported by Li and Higgs (2005) for binding of lon-
ger dimeric N-terminal constructs to a similar DAD seg-
ment. Using fluorescence anisotropy, they measured
a Kd of 250 nM for binding of both mDia1 1–548 and
129–548 to a FITC-labeled 25 residue DAD peptide.
The similar binding affinities of the DID domain to DAD
versus FH2+DAD proteins lead us to conclude that inter-
actions between the DID and FH2 domain contribute
modestly, if at all, to the affinity of the autoinhibitory in-
teraction. This interpretation is further supported by our
observation that the bound DAD peptide occupies the
entire conserved surface on the DID domain. It is impor-
tant to note that these experiments do not address pos-
sible interactions of the dimerization domain, and that
we do not rule out the possibility of energetically neutral
interactions of the DID and FH2 domains.
Mechanism of Rho Activation
The activation of autoinhibited mDia1 requires the Rho-
induced displacement of the DAD domain. How is this
accomplished? The GTP bound RhoA binds the
GBD+DID fragment of mDia1 an order of magnitude
more tightly than does the DAD segment. We measure
a Kd of 9 nM by using ITC (Figure 4E), which is consistent
with previously reported values determined by using
stopped-flow fluorescence methods (Rose et al.,
2005). The tighter binding is achieved through enthalpi-
cally favorable interactions, consistent with the numer-
ous electrostatic interactions in the binding interface
Structure
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(A) Surface representation of DID, colored according to conserva-
tion among DRFs (blue to white to red with increasing conservation).
Note the highly conserved patch consisting of residues Leu163,
Asn217, Asn218, Ala256, Gln352, and Asn310.
(B) Highly conserved residues interacting with DAD are shown in
pink. Previous structure/function analysis (Alberts, 2001) of the
DAD segment reveals that residues Met1182, Leu1185, and
Leu1189 (red side chains) are required for autoinhibition, but that
Ser1182, Glu1187, and Gln1190 are not (green side chains).
(C) Multiple sequence alignment of residues at the DID/DAD inter-
face in DRF formins. Top alignment, DID domain; bottom alignment,
DAD domain. Residues involved in the autoinhibitory interaction in
mDia1 are highlighted. High conservation of these residues in all
mDia formins as well as mammalian Daam1 and Fmnl1 (also called
Frl) and yeast Bnr1p points to a similar mechanism of autoinhibition
in these formins. Yeast Bni1p and mammalian FHOD1, on the other
hand, exhibit more sequence diversity.between Rho and mDia1 (Rose et al., 2005). Thus, the
higher-affinity GTP bound Rho can out-compete the
DAD segment for binding to the DID domain if their bind-
ing sites significantly overlap. Indeed, previous studies
that mapped the DAD binding site indicated partial over-
lap with the Rho-interacting surface and led to this
Figure 4. Analysis of Binding of DID, DAD, and Adjacent Domains
with Isothermal Titration Calorimetry
(A–D) The DID or GBD+DID protein was injected into either GST-DAD
or FH2+DAD, as indicated, and binding constants were determined.
Note that all titrations are endothermic, and that they yield modest
variation for the dissociation constant; the longest construct has
the tighter binding constants, and the shortest construct has the
weaker binding constants. The apparent fraction of active protein
is less than 100%, likely due, in part, to a small amount of proteolytic
cleavage of the DAD peptide from the GST-DAD and FH2-DAD pro-
teins.
(E) Rho-GTP was injected into GBD-DID protein. The interaction is
exothermic, and the calculated dissociation constant is an order of
magnitude tighter than that of the autoinhibitory DID/DAD interac-
tion. This higher-affinity binding of Rho-GTP is consistent with its
ability to induce dissociation of the DAD segment and thereby acti-
vate the formin.
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(A) Ribbon diagram of a GBD-DID-DD dimer in complex with RhoC
(Rose et al., 2005). The mDia1 GBD is shown in red, the DID is shown
in blue, and the DD is shown in pink on one side of the dimer, and
Rho is shown in green. The other subunit of the dimer is shown in
gray. The DAD binding region is encircled, and it is displayed in detail
in (B) and (C).
(B) The autoinhibitory DID/DAD complex is shown superimposed on
the Rho complex. The DAD domain is shown as a yellow stick model
with a transparent surface. Note the steric clashes primarily between
the GBD domain and DAD. Also note the possibility of electrostatic
repulsion between two acidic residues, Glu64 and Asp65, in the
switch II region of Rho and acidic residues, Asp1183 and Glu1187,
on the exposed surface of the DAD helix.
(C) Close-up view demonstrating the steric occlusion of the DAD
binding site in the Rho complex. Note that GBD residues 92–97
and Rho residue Arg68 clash with the N-terminal portion of thehypothesis (Otomo et al., 2005a; Rose et al., 2005). The
present structure allows us to directly compare the
binding sites of Rho versus the DAD segment on the sur-
face of the DID domain. The structure of the mDia1 N ter-
minus in complex with RhoC is shown in Figure 5A (Rose
et al., 2005), and the present DAD complex is shown
superimposed with this structure in Figures 5B and 5C.
Surprisingly, only one residue in RhoA directly impinges
on the DAD binding site. Arg68 is located in the switch II
region of Rho, and its side chain inserts between the
GBD and the first armadillo repeat of the DID domain,
where it hydrogen bonds with Asn217. Although the ste-
ric clash of Arg68 is modest (it would directly clash with
the side chain of Thr1179 in the DAD peptide), the intro-
duction of this residue into the DAD binding cleft is likely
to be mechanistically significant because it would pre-
clude Asn217 from making the helix-capping hydrogen
bond with the DAD peptide. We also note that two acidic
residues in the switch II region of Rho (Glu64 and Asp65)
project within 3.5–5 A˚ of acidic residues on the exposed
surface of the DAD helix (Asp1183 and Glu1187, Fig-
ure 5B). Thus, electrostatic repulsion may also contrib-
ute to expulsion of the DAD segment.
More strikingly, a 6 residue segment of the GBD sub-
domain (residues 92–97) in the Rho complex sterically
occludes the binding surface of residues 1177–1180 of
the DAD domain (Figure 5). In the absence of Rho, the
GBD region is not rigidly structured ([Otomo et al.,
2005a] and our unpublished data), and, therefore, it
does not affect binding of the DAD domain (Figure 4).
Rho binding rigidifies the GBD and locks it into position
in apposition with the adjacent DID domain, where it
directly occludes this portion of the DAD binding site
(Figures 5B and 5C). The use of an unstructured or ‘‘con-
tingently folded’’ segment (the GBD in this case) is a
common feature in the release mechanism of ras-family
GTPase effectors (Lei et al., 2000). The CRIB motif of the
p21-activated kinase PAK1 is perhaps the best-charac-
terized example (Jaffer and Chernoff, 2002; Lei et al.,
2000, 2005; Parrini et al., 2002; Morreale et al., 2000).
This construction has been proposed to provide an ‘‘ac-
cess point’’ for initial contact of the activated GTPases
(Otomo et al., 2005a). In mDia1, the available structural
data are consistent with a model in which GTP bound
Rho could first interact weakly with the GBD alone
and, in a second step, induce the reorientation of the
GBD and insertion of Arg68 to effect ejection of the
bound DAD peptide (Otomo et al., 2005a; Rose et al.,
2005). A simpler model is also plausible; Rho might ex-
ploit transient dissociation of the weaker binding DAD
segment and bind in a single step to preclude reassoci-
ation of the autoinhibitory DAD domain. Further struc-
ture-function studies will be required to discriminate be-
tween these models. For example, judicious mutation of
Arg68 might maintain all binding interactions of Rho with
the GBD, but diminish Rho interaction with the DID do-
main and thereby allow trapping of the ternary complex
with Rho and DAD both bound to the mDia N terminus—
if indeed such an intermediate is relevant to formin ac-
tivation. Although active RhoA is able to completely
superimposed DAD peptide. Thus, binding of Rho and the concom-
itant restructuring of the GBD domain preclude simultaneous bind-
ing of the autoinhibitory DAD segment and promote mDia activation.
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a competition assay (Rose et al., 2005), Rho appears to
only partially relieve DAD-mediated autoinhibition of ac-
tin assembly in vitro (Li and Higgs, 2005). This observa-
tion suggests the possibility that other proteins or mech-
anisms might also be involved in activation of DRFs.
The oligomeric state of formins has not been defini-
tively established, but the intact protein is likely to be
at least dimeric, as both the N-terminal region and the
FH2 domain form stable dimers. Thus, we anticipate a bi-
valent interaction between the dimeric N-terminal region
and the C-terminal DAD domain. Because the DAD do-
main lies w40 residues beyond the end of the FH2 do-
main, the available structures provide little insight into
how the DID/DAD interaction may inhibit the function
of the FH2 domain. Elucidation of this issue will require
structural analysis of larger N- and C-terminal fragments
or of an intact formin.
Experimental Procedures
Protein Expression, Purification, and Crystallization
The DNA sequence encoding residues 1174–1200 of mDia1 was am-
plified by PCR and ligated into a modified pET vector containing
a GST tag with a TEV cleavage site. Expression of the fusion protein
in E. coli BL21 (DE3) was induced by IPTG and was allowed to pro-
ceed overnight at 23ºC. The cells were harvested and resuspended
in 50 mM Tris (pH 8), 150 mM NaCl, and 200 mg/ml lysozyme and
were stored at 280ºC. Upon thawing and after the addition of
1 mM PMSF and 2 mM TCEP, the cells were lysed by sonication
and cleared by centrifugation. GST-Sepharose equilibrated with
buffer A (20 mM Tris [pH 8], 100 mM NaCl, 2 mM TCEP) was added
to the cleared lysate. After gentle rocking for 30 min at room temper-
ature, the beads were washed with buffer A, followed by buffer A
plus 400 mM NaCl, and once again with buffer A. To form the DID/
DAD complex, purified DID protein was added to the bound GST-
DAD protein and allowed to mix for 30 min at room temperature. Ex-
cess, unbound DID was removed by extensive washing with buffer
A. The DID/DAD complex was cleaved from the column by overnight
incubation at room temperature with TEV protease. The freely eluted
DID/DAD complex was collected, concentrated, and loaded onto
a gel filtration column (Superdex75) equilibrated with buffer A. The
DID/DAD complex was concentrated to 13.1 mg/ml and was stored
at 280ºC.
The DID/DAD complex was crystallized at 20ºC by hanging-drop
vapor diffusion against 0.1 M sodium citrate (pH 6.0) and 200 mM
ammonium sulfate salt with 25% PEG 4000 as precipitant. Crystals
grew overnight and were cryo-protected with 20% glycerol in drop
mother liquor prior to flash freezing in liquid nitrogen. Crystals be-
long to the space group C2 with unit cell dimensions a = 102.15 A˚,
b = 65.79 A˚, c = 46.86 A˚ and contain a single complex in the asym-
metric unit.
Crystallographic Data Collection and Structure Determination
Diffraction data were collected in house on a Rigaku RU300-RC
rotating anode X-ray generator with osmic confocal Max-Flux
(CMF12-38Cu6) optics and a Mar345dtb image plate area detector,
and they were processed with XDS (Kabsch, 1993). Structure deter-
mination by molecular replacement was implemented with PHASER
(CCP4, 1994; Otwinowski and Minor, 1997) by using the DID domain
portion of the mDia1 N terminus as the search model (Otomo et al.,
2005a). The correct solution yielded a log (likelihood) gain of 249.631
in the 10–3.2 A˚ resolution range for the mDia1 DID/DAD construct.
The program Arp-Warp was used to build from the molecular re-
placement model in an automated fashion (Brunger et al., 1998;
Lamzin and Wilson, 1997), and repeated rounds of manual refitting
and crystallographic refinement were performed in COOT (Emsley
and Cowtan, 2004), CNS v1.1 (Brunger et al., 1998), O (Jones and
Kjeldgaard, 1997), and Refmac1 (CCP4, 1994). The final model con-
tains residues 135–367 of DID (with a gap between residues 194–
198), residues 1177–1196 of the DAD domain, and 126 water mole-cules, and it has been refined to an R value of 21% (Rfree = 28%)
with excellent stereochemistry (Table 1). Very low-resolution data
(>8 A˚) were excluded from the refinement due to poor scaling
(even after application of bulk solvent correction).
Isothemal Titration Calorimetry
Isothermal titration calorimetry experiments were performed by us-
ing a high-precision VP-ITC system (Microcal, Inc.). The GST-tagged
DAD fragment (residues 1175–1200) or the FH2-DAD protein (resi-
dues 736–1200) was titrated with either DID (residues 131–369) or
GBD-DID protein (residues 72–369). As a control, DID was also ti-
trated into GST protein alone. All protein solutions were prepared
by dialysis against 20 mM Tris (pH 8.0), 100 mM sodium chloride,
and 2 mM TCEP overnight at 4ºC. Protein concentrations were de-
termined by using a Coomassie binding assay (with BSA as stan-
dard) and confirmed by comparing the values with their absorbance
at 280 nm by using theoretical extinction coefficients in guanidine
hydrochloride. The final concentrations of protein for each experi-
ment as shown in Figure 4 is as follows: Figure 4A, [DID] = 500 mM,
[GST-DAD] = 80 mM; Figure 4B, [GBD-DID] = 176 mM, [GST-DAD] =
20 mM; Figure 4C, [DID] = 200 mM, [FH2-DAD] = 20 mM; Figure 4D,
[GBD-DID] = 176 mM, [FH2-DAD] = 20 mM; Figure 4E, [GBD-DID] =
176 mM, [RhoA] = 20 mM, [GTP] = 50 mM, for the injectant and cell con-
tent, respectively. Given the binding constant of 100–200 nM for the
DID/DAD interaction, these concentrations would yield a C value of
200–300 for the titrations (C = [protein in cell]/Kd), which is within the
acceptable range for isothermal titration calorimetry. All protein
samples were degassed for 20 min prior to use. The heat evolved af-
ter each injection was obtained from the integral of the calorimetric
signal. The GBD-DID or DID protein was titrated into the GST-DAD or
FH2-DAD protein, and Rho-GTP was titrated into GBD-DID. All titra-
tions were conducted at 20ºC, and the volume in all cases was 10 ml
per injection Analysis of the data was performed by using the ITC
module of the Origin software (OriginLab Corp.).
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